We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$549M
AUM Growth
+$11.4M
Cap. Flow
+$699K
Cap. Flow %
0.13%
Top 10 Hldgs %
43.1%
Holding
74
New
4
Increased
27
Reduced
32
Closed
4

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$18M
2
AVT icon
Avnet
AVT
+$15.2M
3
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$7.42M
4
STT icon
State Street
STT
+$6.35M
5
MAT icon
Mattel
MAT
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 31.8%
2 Industrials 13.52%
3 Financials 12.84%
4 Technology 12.05%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$117B
$38.6M 7.02%
444,303
-2,879
-0.6% -$233K
TEVA icon
2
Teva Pharmaceuticals
TEVA
$42.5B
$29.9M 5.44%
594,581
+26,305
+5% +$1.4M
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$27.9M 5.07%
229,608
-7,240
-3% -$823K
MSFT icon
4
Microsoft
MSFT
$3.81T
$25.2M 4.6%
493,422
+73,374
+17% +$3.81M
VZ icon
5
Verizon
VZ
$208B
$21.2M 3.87%
379,989
-65,749
-15% -$3.41M
JCI icon
6
Johnson Controls International
JCI
$84.6B
$20.1M 3.66%
432,893
+22,296
+5% +$982K
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$19M 3.46%
227,873
+4,578
+2% +$369K
PFE icon
8
Pfizer
PFE
$159B
$18.5M 3.38%
554,504
-571
-0.1% -$18.2K
ORCL icon
9
Oracle
ORCL
$435B
$18.2M 3.32%
445,392
+105,955
+31% +$4.23M
WFC icon
10
Wells Fargo
WFC
$262B
$18M 3.28%
380,889
+374,578
+5,935% +$18.3M
BAX icon
11
Baxter International
BAX
$13.5B
$16.2M 2.95%
358,068
+1,653
+0.5% +$72.5K
MET icon
12
MetLife
MET
$61.3B
$15.2M 2.77%
428,509
-24,043
-5% -$938K
UNP icon
13
Union Pacific
UNP
$183B
$15M 2.74%
172,398
-1,377
-0.8% -$116K
BG icon
14
Bunge Global
BG
$22.2B
$14.3M 2.61%
242,422
-10,981
-4% -$672K
AXP icon
15
American Express
AXP
$225B
$12.5M 2.27%
+205,289
New +$13M
TUP
16
DELISTED
Tupperware Brands Corporation
TUP
$12.2M 2.22%
216,691
-27,762
-11% -$1.58M
GWW icon
17
W.W. Grainger
GWW
$61.5B
$12M 2.18%
52,672
+5,193
+11% +$1.18M
CHKP icon
18
Check Point Software Technologies
CHKP
$14.1B
$11.8M 2.16%
148,646
-34
-0% -$2.85K
PPL
19
PPL Corp
PPL
$25.7B
$10.9M 1.98%
287,859
-56,256
-16% -$2.14M
APA icon
20
APA Corp
APA
$14.9B
$10.4M 1.9%
187,662
-1,646
-0.9% -$89.5K
RTX icon
21
RTX Corp
RTX
$285B
$9.53M 1.74%
147,624
+64,575
+78% +$4.13M
MRK icon
22
Merck
MRK
$366B
$8.59M 1.57%
156,281
-853
-0.5% -$45.4K
EMR icon
23
Emerson Electric
EMR
$86.6B
$8.55M 1.56%
163,884
-24,981
-13% -$1.33M
TIF
24
DELISTED
Tiffany & Co.
TIF
$8.11M 1.48%
+133,773
New +$8.89M
ICL icon
25
ICL Group
ICL
$7.23B
$7.83M 1.43%
2,008,715
+16,631
+0.8% +$71.5K

Similar funds

Foyston, Gordon, & Payne's Q2 2016 Portfolio in Review

As of Q2 2016, Foyston, Gordon, & Payne held 74 positions worth $549M, up 2.1% from $537M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Foyston, Gordon, & Payne's Q2 2016 filing shows 4 new, 27 increased, 32 reduced and 4 closed positions. Its largest new stake was American Express: 205,289 shares worth $12.5M. The largest sale was PNC Financial Services, an estimated $18M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 32% a quarter earlier, followed by Industrials and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2016 buy was American Express: 205,289 shares worth $12.5M.
  • Foyston, Gordon, & Payne added most to Wells Fargo in Q2 2016, an estimated $18.3M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2016 reduction was State Street, cutting an estimated $6.35M.
  • Foyston, Gordon, & Payne fully exited PNC Financial Services in Q2 2016, selling an estimated $18M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 43% of its $549M portfolio in Q2 2016.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 4 in Q2 2016.
  • Foyston, Gordon, & Payne's portfolio value rose 2.1% quarter-over-quarter to $549M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2016, filed 11 Aug 2016.